AGP Executive Report
Last update: 9 hours agoMedical Device Safety: Boston Scientific is removing and discontinuing its single-use Imager II angiographic catheters after an FDA warning that the catheter tip can degrade or detach, raising the risk of procedure delays and rare life-threatening embolism. Cybersecurity & Supply Chains: The company also says its cyberattack has disrupted systems used to process and ship orders, with no set timeline for full restoration. Biotech & Immunology: Boston University researchers identified specialized lung-vein cells that become active after injury and help drive lung fibrosis, pointing to a new signaling target. Cancer Care: In renal cell carcinoma after anti–PD-(L)1 therapy, belzutifan plus lenvatinib showed patient-reported outcomes comparable to cabozantinib in LITESPARK-011. Public Health & Policy: A Boston University-led study finds nearly 20% of Medicaid expansion adults in some states may struggle to meet new federal work-hour rules, putting coverage at risk. STEM Workforce & Research Mobility: Canada is recruiting 64 researchers, including many from Harvard, Cornell, and MIT, as U.S. funding pressure pushes talent north. AI in Government Services: The VA launched an AI helpdesk chatbot in beta, with plans to expand personalization and live-agent support later this year. Space & Education: Trump visited NASA’s Johnson Space Center and floated a U.S. Space Academy concept, with details still forming.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
